Founded in 2005, Korea Institute for Pharmaceutical Policy Affairs, KIPPA, is a non-profit, public foundation, approved by the Korean Ministry of Health and Welfare. The institute is contributed by three relevant parties, the Korean Pharmaceutical Association (KPA), the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KBPMA), and the Korea Pharmaceutical Distribution Association (KPDA).

KIPPA is a leading research center, which aims to promote public health through the development of policy regarding the rational use of medicines, pharmacy education, pharmacy practice, pharmaceutical industry, and pharmaceutical supply and distribution. In particular, we begin to develop ¡®a community pharmacy model as a health promotion center for community members¡¯. We are collecting and analysing big data accordingly to develop pharmacy-based policies, which pursue maximised pharmacy practice for all the Koreans.

In consequence, KIPPA will consistently implement research tailored to the promotion of health in the nation and worldwide. We kindly ask for supports from our fellow pharmacists, public and associations.

If you have any further enquiries about the institute or research in English, please contact us via e-mail (kippa.org@gmail.com).

Thank you.

Office Address
3FL, 194, Hyoryeong-ro, Seocho-gu, Seoul, Repbulic of Korea

ÇöÀçÀ§Ä¡ : Home : ¾Ë¸²¸¶´ç : ¿¬±¸¼Ò ´º½º
   
¾Ë¸²¸¶´ç
°øÁö»çÇ×
º¸µµÀÚ·á
ÀÎÀçä¿ë
 
 
Á¦   ¸ñ [´ëÇѾà»çÀú³Î]Âü°¡ÀÚ ¡®¸¸Á·µµ¡¯ ³ô¾Æ, ±³À° Áö¼Ó¼º ÇÊ¿ä
³»   ¿ë

Âü°¡ÀÚ ¡®¸¸Á·µµ¡¯ ³ô¾Æ, ±³À° Áö¼Ó¼º ÇÊ¿ä

Àå¾ÖÀÎ ´ë»ó ÀǾàǰ ¾ÈÀü»ç¿ë ±³À° Æò°¡ °á°ú <5>


<Áö³­È£¿¡ À̾>
Àå¾ÖÀΠ´ë»ó ÀǾàǰ ¾ÈÀü»ç¿ë ±³À° Æò°¡
(2) Ã»°¢ Àå¾ÖÀΠ´ë»ó ±³À° Æò°¡
³ª) ±³À° ¸¸Á·µµ
1) ±³À°ÀÇ µµ¿òÁ¤µµ ¹× ÀÌÇØµµ
¡â±³À° ´ë»óÀÚÀÇ ±³À° ¸¸Á·µµ¸¦ Æò°¡Çϱâ À§ÇØ ±³À°ÀÇ µµ¿òÁ¤µµ, ±³À°ÀÇ ÀÌÇØµµ µîÀ» ÆÄ¾ÇÇÔ
-Âü¿©ÇÑ ÀǾàǰ ¾ÈÀü»ç¿ë ±³À°ÀÌ µµ¿òÀÌ µÆ´Ù°í ÀÀ´äÇÑ ºñÀ²ÀÌ 91.6%¿´À¸¸ç, ±³À°ÀÌ ÃæºÐÈ÷ ÀÌÇØµÆ´Ù°í ÀÀ´äÇÑ ºñÀ²Àº 57.4%·Î ³ªÅ¸³²

-±³À° Âü¿©ÀÚÀÇ 84.3%°¡ °­Àdz»¿ë°ú º»ÀÎÀÇ ¾à »ç¿ë¹æ¹ý¿¡ Â÷À̰¡ ÀÖ´Ù°í ÀÀ´äÇÔ


2) ÇâÈÄ ±³À° Âü¿© ÀÇÇâ ¹× ¿ä±¸»çÇ×
¡âÃßÈÄ ÀǾàǰ ¾ÈÀü»ç¿ë ±³À°¿¡ Âü¿©Çϰڴٰí ÀÀ´äÇÑ ºñÀ²Àº 97.2%·Î ³ô°Ô ³ªÅ¸³µÀ¸¸ç, Ãß°¡ÀûÀ¸·Î ÇÊ¿äÇÑ »çÇ×À¸·Î´Â ´Ù¾çÇÑ ÁÖÁ¦ÀÇ ±³À°ÀÌ ÇÊ¿äÇϴٴ Àǰ߰ú ÀÇ»ç¼ÒÅëÀÇ ¾î·Á¿òÀ» ÇذáÇÒ ¼ö Àִ ¹æ¾È¿¡ ´ëÇÑ ¿ä±¸°¡ ³ô¾ÒÀ½

-ÇâÈÄ ±³À° ÁøÇàÀ» À§ÇØ °³¼±ÀÌ ÇÊ¿äÇÑ »çÇ׿¡ ´ëÇÑ ÀǰßÀ¸·Î´Â, °üÀý¿°À̳ª ¿µ¾ç µî ´Ù¾çÇÑ ÁÖÁ¦¿¡ ´ëÇÑ ±³À°ÀÌ ÇÊ¿äÇϸç, Á¤±âÀûÀΠÃß°¡±³À°Àº ¹°·Ð ¾à±¹ ¹æ¹® ½Ã µîÀ» Æ÷ÇÔÇØ Ã»°¢ Àå¾ÖÀΰúÀÇ ÀÇ»ç¼ÒÅëÀÇ ¹®Á¦¿¡ ´ëÇÑ ÇØ°áÀÌ ÇÊ¿äÇϴٴ ÀǰßÀÌ ÀÖ¾úÀ½

(3) Àå¾ÖÀΠ´ã´ç ±³»ç ´ë»ó ±³À° Æò°¡
¡â½Ã°¢ ¹× Ã»°¢ Àå¾ÖÀΠÀ̿ܿ¡µµ ¹ß´ÞÀå¾ÖÀΰú ´ã´ç ±³»ç¸¦ ´ë»óÀ¸·Î ÀǾàǰ ¾ÈÀü»ç¿ë ±³À°ÀÌ ÃÑ 3ȸ ÁøÇàµÆÀ¸¸ç, ÃÑ 52¸í(Àå¾ÖÀΠ32¸í, ´ã´ç±³»ç 20¸í)ÀÌ ±³À°¿¡ Âü¿©ÇÔ. ÀÌÁß Àå¾ÖÀΠ´ã´ç ±³»ç 20¸íÀ» ´ë»óÀ¸·Î ±³À° Æò°¡¸¦ ÁøÇàÇÔ

°¡) ÀϹÝÀû Æ¯¼º
¡â±³À° Âü¿©ÀÚÀÇ ÀϹÝÀû Æ¯¼ºÀ» »ìÆìº¸¸é ´ÙÀ½°ú °°À½
-¿©¼ºÀÇ ºñÀ²ÀÌ Á¶±Ý ³ô¾ÒÀ¸¸ç, Àý¹ÝÀÌ»óÀÌ 30~40´ë·Î ±Ù¹«°æ·ÂÀº 1~5³â ¹Ì¸¸ÀÌ °¡Àå ¸¹À½

-±³À°¿¡ Âü¿©ÇÑ Àå¾ÖÀΠ´ã´ç ±³»çÀÇ ´ëºÎºÐÀº ÀÌÀü¿¡ ÀǾàǰ ¾ÈÀü»ç¿ë ±³À°À» ¹ÞÁö ¸øÇß´Ù°í ÀÀ´äÇÔ

³ª) ±³À° ¸¸Á·µµ
1) ±³À°ÀÇ µµ¿òÁ¤µµ
¡â±³À° ´ë»óÀÚÀÇ ±³À° ¸¸Á·µµ¸¦ Æò°¡Çϱâ À§ÇØ ±³À°ÀÇ µµ¿òÁ¤µµ¸¦ ÆÄ¾ÇÇÔ
-Âü¿©ÇÑ ¸ðµç Àå¾ÖÀΠ´ã´ç ±³»ç°¡ ÀǾàǰ ¾ÈÀü»ç¿ë ±³À°ÀÌ µµ¿òÀÌ µÆ´Ù°í ÀÀ´äÇÔ

-±³À° Âü¿©ÀÚÀÇ 25.0%°¡ °­Àdz»¿ë°ú ±× °£ ¾à¹°º¹¿ë °ü·Ã ¾È³»»çÇ׿¡ ÀÖ¾î Â÷À̰¡ ÀÖ´Ù°í ÀÀ´äÇÔ

2) ÇâÈÄ ±³À° Âü¿© ÀÇÇâ ¹× ¿ä±¸»çÇ×
¡âÃßÈÄ ÀǾàǰ ¾ÈÀü»ç¿ë ±³À°¿¡ Âü¿©Çϰڴٰí ÀÀ´äÇÑ ºñÀ²Àº 100%·Î ±³À°¿¡ ´ëÇÑ ¿ä±¸µµ°¡ ¸Å¿ì ³ô¾ÒÀ¸¸ç, Ãß°¡ÀûÀ¸·Î ÇÊ¿äÇÑ »çÇ×À¸·Î´Â ºÎÀÛ¿ë ¹× ´ëó¹æ¾È¿¡ ´ëÇÑ ±³À°°ú Áö¼ÓÀûÀΠ±³À°Áö¿ø¿¡ ´ëÇÑ ¿ä±¸°¡ ÀÖ¾úÀ½

³ª°¡¸ç 
¾Õ¼­ ¼Ò°³µÈ ÀǾàǰ ¾ÈÀü»ç¿ë ±³À° ÈÄ ÀϺΠÀå¾ÖÀÎ(½Ã°¢ ¹× Ã»°¢) ¹× Àå¾Ö±³»çµéÀ» ´ë»óÀ¸·Î ÀÚ¹®È¸ÀǸ¦ 3Â÷·Ê ½Ç½ÃÇÑ °á°ú, ´ëüÀûÀ¸·Î °­»çÀÇ ¼³¸íÀÌ ½±°í, ±³À°³»¿ëÀÌ Àå¾ÖÀεéÀÇ »óȲ¿¡ Àß ¸Â´Â´Ù´Â ÀǰßÀÌ ÁÖ¸¦ ÀÌ·ç¾ú´Ù. 

½Ã°¢Àå¾ÖÀÎÀÇ °æ¿ì, ÀüÀûÀ¸·Î ¼Ò¸®¿¡ ÀÇÁ¸ÇϹǷΠ°­»çÀÇ ¼³¸íÀÌ ¸Å¿ì Áß¿äÇϸç, ÄÜÅÙÃ÷¿Í Ä¿¸®Å§·³ÀÌ ±³À°º°·Î µ¿ÀÏÇϰԠ¸¶·ÃµÅ À־ °­»ç¿¡ µû¶ó¼­ ±³À° ³»¿ëÀÇ Àü´Þ¿¡ Â÷À̰¡ Å¬ ¼ö ÀÖ´Ù. 

ÀÌ¿¡ ±×¸²ÀÚ·á¿¡ ´ëÇÑ ±¸Ã¼ÀûÀΠ¼³¸íÀÌ ÇÊ¿äÇϰí, Á÷Á¢ ¼ÕÀ¸·Î ¸¸Áö°í Ã¼ÇèÇÒ ¼ö Àִ ±³±¸½Ç½ÀÀÌ È¿°úÀûÀÏ ¼ö Àִٴ ÀǰßÀÌ Á¦½ÃµÆ´Ù.

û°¢Àå¾ÖÀΠ´ë»ó ±³À°ÀÇ °æ¿ì, ½Ã°¢ÀÚ·áÀÇ Àû±ØÀûÀΠȰ¿ëÀÌ ÇÊ¿äÇϸ砳óÀε鵵 Àֱ⠶§¹®¿¡ ¼öÈ­Å뿪À» °°ÀÌ ÇÑ Á¡ÀÌ ÀÌÇØ¿¡ µµ¿òÀÌ µÈ °ÍÀ¸·Î ³ªÅ¸³µ´Ù. 

¹ß´ÞÀå¾ÖÀνü³ ±³»ç ´ë»ó ±³À°¿¡ ´ëÇÑ Á¦¾ÈÁ¡À¸·Î´Â ¿Ü»ó°ü¸®¸¦ À§ÇÑ ±³À°°ú º¸È£ÀÚ ´ë»ó ±³À°, Á¤½Å°ú ¾à°ú »óºñ¾àÀÇ »óÈ£ÀÛ¿ë¿¡ ´ëÇÑ ±³À°ÀÌ ÇÊ¿äÇÑ °ÍÀ¸·Î ³ªÅ¸³µ´Ù. 

À̾øÅëÀǰßÀ¸·Î ±³À°ÀÌ Á¤±âÀûÀ¸·Î ÁøÇàµÇ°í, Áúº´¿¡ ´ëÇÑ ÇÙ½ÉÁ¤º¸ ¹× ºÎÀÛ¿ë Á¤º¸, ¾à¹°»óÈ£Àۿ렵 ´ëÇÑ ³»¿ëÀ» ±³À°³»¿ë¿¡ Ãß°¡Çϴ °Í¿¡ ´ëÇÑ ÀǰßÀÌ ÀÖ¾ú´Ù. 

½Ã°¢Àå¾ÖÀÎÀÇ ÀÇ·á±â°ü À̿렽àºÒÆí»çÇ× ¹× °³¼±Á¡À¸·Î º¹¾àÁ¤º¸¿¡ ´ëÇÑ ¹®ÀÚ¼­ºñ½º, À½¼ºº¯È¯±â±â »ç¿ëÀ» À§ÇÑ ¾à»çÀÇ µµ¿ò, ¾ß°£ ÀÀ±Þ »óȲ ½ÃÀÇ Äɾî, º¹¾à ½ÃÁ¡ ±¸º°À» À§ÇØ ¾àºÀÅõ Å©±â³ª ÀçÁúÀ» ´Ù¸£°Ô Á¦°ø, Åõ¾à ¿©ºÎ ¾Ë¸² ±â´É ¼­ºñ½º, Á¡Àڠǥ½ÃµÈ ¾à ±¸ÀÔ °æ·Î Á¦°ø µîÀÌ ÀÖ¾ú´Ù. 

û°¢Àå¾ÖÀÎÀÇ ÀÇ·á±â°ü À̿렽àºÒÆí»çÇ× ¹× °³¼±Á¡À¸·Î´Â º¸°ÇÀÇ·áÀü¹®°¡°¡ È¯ÀÚ¸¦ º¸¸é¼­ À̾߱âÇϵµ·Ï Çϰí, ÇÑ ¾à±¹À» ÁöÁ¤Çؼ­ ¹æ¹®, ¾à»ç ¿¬¼ö±³À°¿¡ Àå¾ÖÀο¡ ´ëÇÑ ÀÌÇØµµ¸¦ ³ôÀ̴ ±³À°³»¿ë ¹Ý¿µ, ¾à»çÀÇ ÃæºÐÇÑ º¹¾àÁöµµ, À̸§ È£¸í ´ë½Å ¹øÈ£ÆÇÀ̳ª Áøµ¿º§ »ç¿ë, ÇÊ´ãÀ» ÅëÇÑ ÀÇ»ç¼ÒÅë, Ã³¹æÀü¿¡ Ã»°¢Àå¾ÖÀÎÀÓÀ» Ç¥½Ã µîÀÌ Á¦½ÃµÆ´Ù. 

¹ß´ÞÀå¾ÖÀÎÀÇ ÀÇ·á±â°ü À̿렽àºÒÆí»çÇ× ¹× °³¼±Á¡À¸·Î ÀÇ·áÀü¹®°¡°¡ È¯ÀÚ¸¦ º¸°í À̾߱âÇϵµ·Ï Çϰí, º¹¿ëÇϴ Á¤½Å°ú ¾à¿¡ ´ëÇÑ ¼³¸í, ¾à±¹ ÇѰ÷À» ÁöÁ¤Çؼ­ Áö¼ÓÀûÀ¸·Î ¹æ¹®, º¹¾àÁöµµ ½Ã ÃµÃµÈ÷ ½±°Ô ¸»Çϱâ, ½Ã°¢ÀÚ·á È°¿ë, ¾à»ç ¿¬¼ö±³À°¿¡ Àå¾ÖÀο¡ ´ëÇÑ ÀÌÇØµµ¸¦ ³ôÀ̴ ±³À°³»¿ë ¹Ý¿µ µîÀÌ ÀÖ¾ú´Ù. 

ÀÌó·³ ÁÖ¿ä ¼±Áø±¹¿¡¼­ ½ÃÇ࠵ǰí Àִ ÀǾàǰ ¾ÈÀü »ç¿ë ¹æ¹ý ¹× ¾à»çÀÇ ¿ªÇÒ, ±×¸®°í ½Ã°¢, Ã»°¢, ¹ß´ÞÀå¾Ö µî Àå¾ÖÀÇ Á¾·ù¿Í À¯Çü, Á¤µµ¿¡ µû¸¥ ¾à±¹ ¹× ÀÇ·á±â°ü À̿렽àºÒÆí»çÇ× ¹× °³¼±Á¡ µî¿¡ ´ëÇÑ ÀÚ¹®È¸ÀÇ °á°úµéÀ» Åä´ë·Î Àå¾ÖÀεéÀÇ ¿Ã¹Ù¸¥ ÀǾàǰ »ç¿ëÀ» µµ¿ï ¼ö Àִ ´Ù¾çÇÑ ¹æ¾ÈµéÀÌ Áö¼ÓÀûÀ¸·Î ³íÀÇ µÇ°í, Ã¼°èÀûÀ¸·Î º¯È­¹ßÀüÇØ ³ª¾Æ°¥ ¼ö Àֱ⸦ ±â´ëÇϴ ¹ÙÀÌ´Ù.

[±â»çÃâó] https://www.kpanews.co.kr/academy/show.asp?page=1&search_cate=8&idx=314

 

¹øÈ£ ÷ºÎ Á¦¸ñ ÀÛ¼ºÀÚ ÀÛ¼ºÀÏ Á¶È¸
92 [¸ÞµðÆÄ³ª´º½º]'Äڷγª19 ´ëÀÀ¡¤ÅëÇÕµ¹º½' ´Ù·é ÀǾàǰÁ¤Ã¥¿¬±¸ ¹ß°£  ±è¼±Èñ 2021-01-19 4
91 [¾à»ç°ø·Ð] ¾à±¹ °ÅÁ¡ Àڻ쿹¹æ»ç¾÷, »ý¸íÁöÅ´ÀÌ ¿ªÇÒ 'ÅåÅå'  ±è¼±Èñ 2021-01-19 3
90 [µ¥Àϸ®ÆÊ] ÀϺ»¾à±¹ÀÇ ÁøÈ­¡¦Ä«µå·Î 'Áߺ¹Åõ¾à¡¤³²Àº ¾à °ü¸®±îÁö'  ±è¼±Èñ 2021-01-19 6
89 [´ëÇѾà»çÀú³Î] ¼¼ÀÌÇÁ¾à±¹¡¤¹æ¹®¾à·á µî Ȱµ¿ Áö¼Ó Áõ°¡  ÀÌÁö¿¬ 2021-01-19 3
88 [´ëÇѾà»çÀú³Î] ¾à±¹ ó¹æÁýÁßµµ º¯È­¿Í ¾à±¹¾à»çÀÇ »çȸÀû ¿ªÇÒ Ãß±¸ ÀÌÁö¿¬ 2021-01-13 46
87 [´ëÇѾà»çÀú³Î] ÀåÁ¡Àº Ű¿ì°í ´ÜÁ¡Àº ¾ø¾Ö´Â ±³À°¹æ¹ýÀº? ÀÌÁö¿¬ 2021-01-06 78
86 [´ëÇѾà»çÀú³Î] 'Àڱ⠹ݿµ ¾ç½Ä' ÅëÇØ ¾à±¹ Àü¹®°¡ ±âÁØ ÆÄ¾Ç ÀÌÁö¿¬ 2020-12-29 81
85 [´ëÇѾà»çÀú³Î] CPD °³³ä µîÀå 80³â, ¿ì¸®³ª¶ó´Â ¾ÆÁ÷¡¦ ÀÌÁö¿¬ 2020-12-22 93
84 ¹Ì±¹¡¤¿µ±¹ ¾à»ç, ¿Â¶óÀÎÀ¸·Î ¾î¶»°Ô °øºÎÇϳª ±è¼±Èñ 2020-12-16 96
83 ÀǾàǰÁ¤Ã¥¿¬ "¿Â¶óÀÎ ¿¬¼ö±³À°¿¡ CPD µµÀÔÇØ¾ß" ±è¼±Èñ 2020-12-16 90
82 [´ëÇѾà»çÀú³Î] CPD °³³ä µîÀå 80³â, ¿ì¸®³ª¶ó´Â ¾ÆÁ÷¡¦ ÀÌÁö¿¬ 2020-12-16 78
81 [´ëÇѾà»çÀú³Î] Áö¿ª ¿©°Ç ¸ÂÃá 'Ä¡¸Å¾È½É¸¶À»'+'Ä¡¸Å¾È½É¾à±¹' ¿î¿µ ÀÌÁö¿¬ 2020-12-08 98
80 [´ëÇѾà»çÀú³Î] È£ÁÖ ¾à±¹ÀÇ Ä¡¸Å Äɾî Àü·«Àº? ÀÌÁö¿¬ 2020-12-01 109
79 [¾à»ç°ø·Ð] Ä¡¸Å±¹°¡Ã¥ÀÓÁ¦ '¿Ö ¾à»ç´Â ºüÁ³À»±î'¡¦¿Ü±¹Àº ¾î¶»°Ô? ±è¼±Èñ 2020-11-25 129
78 [µ¥Àϸ®ÆÊ] ³â µÚ Ä¡¸ÅÀα¸ 100¸¸ ½Ã´ë¡¦¾à±¹ ¿ªÇÒÀ» ã¾Æ¶ó ±è¼±Èñ 2020-11-25 131

ÀÌÀü 10ÆäÀÌÁö [1]  [2]  [3]  [4]  [5]  [6]  [7]  ´ÙÀ½ 10ÆäÀÌÁö

 
 

¼­¿ï ¼­Ãʱ¸ È¿·É·Î194, 3Ãþ (Àç)ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò TEL : 02) 3474-5301 / FAX : 02)3474-5306

COPYRIGHT (C) 2006 KOREA INSTITUTE FOR PHARMACEUTICAL POLICY AFFAIRS ALL RIGHTS RESERVED. FOR MORE INFORMATION MAL kippa.org@gmail.com

±âºÎ±Ý ¾È³»